ISRCTN48210491已完成未知
Methotrexate versus expectant management in women with ectopic pregnancy
Academic Medical Center (AMC) (The Netherlands)0 个研究点目标入组 72 人开始时间: 2006年4月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. All haemodynamically stable patients
- •2. greater than 18 years with either a suspected ectopic pregnancy (a visible ectopic pregnancy or an ectopic mass on Trans Vaginal Sonography) and a plateauing serum hCG concentration less than 1500 IU/l or with a Pregnancy of Unknown Location (PUL) and a plateauing serum hCG concentration less than 2000 IU/l (persisting PUL)
排除标准
- •1. Patients with a viable ectopic pregnancy
- •2. Signs of tubal rupture or active intra-abdominal bleeding
- •3. Abnormalities in liver or renal function or in full blood count
研究者
相似试验
进行中（未招募）
不适用
Methotrexate versus expectant management in women with ectopic pregnancy (METEX study) - METEX studyEUCTR2006-003003-39-NLAcademic Medical Center72
已完成
不适用
Methotrexate versus Expectant management in women with ectopic pregnancy.ectopic pregnancyPregnancy of unknown location (PUL)low and plateauing serum hCGmethotrexateexpectant managementNL-OMON25989Academic Medical Center, University of Amsterdam Obstetrics and Gynaecology (H4-205) Meibergdreef 9 1105 AZ AMSTERDAM THE NETHERLANDS tel: +31 20 5663693 fax: +31 20 696348972
尚未招募
4 期
The METEX Study: methotrexate versus expectant management in women with ectopic pregnancyEctopic PregnancyTubal PregnancyNL-OMON30421Academisch Medisch Centrum72
尚未招募
Unknown
Comparing methotrexate and methotrexate with methotrexate with apremilast in modifying biochemical parameters of psoriasis patients.CTRI/2023/03/050882Anisha Biswal
进行中（未招募）
1 期
Impact of concomitant Methotrexate on efficacy, safety and adherence of Ustekinumab-treatment in patients with active Psoriatic Arthritis (MUST-Study)active psoriatic arthritisMedDRA version: 21.0Level: LLTClassification code 10037160Term: Psoriatic arthritisSystem Organ Class: 100000004859EUCTR2015-005777-20-DEFraunhofer Gesellschaft for its Institute Fraunhofer Institute for Translational Medicine and Pharmacology ITMP196